# Investigation of Three Biomarkers for the Detection of Prostate Cancer

> **NCT06554587** · — · RECRUITING · sponsor: **Medtechtomarket Consulting Ltd** · enrollment: 137 (estimated)

## Conditions studied

- Cancer of Prostate

## Interventions

- **DIAGNOSTIC_TEST:** Laboratory Biomarker Analysis: Enzyme-linked immunosorbent assay (ELISA)

## Key facts

- **NCT ID:** NCT06554587
- **Lead sponsor:** Medtechtomarket Consulting Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-07
- **Primary completion:** 2026-01-07
- **Final completion:** 2026-03-07
- **Target enrollment:** 137 (ESTIMATED)
- **Last updated:** 2025-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06554587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06554587, "Investigation of Three Biomarkers for the Detection of Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06554587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*